At Roswell Park Comprehensive Cancer Center, we are committed to delivering the highest quality cancer care and to driving practice-changing discoveries and innovations.
Our exceptional rating by the National Cancer Institute — the highest rating achievable by the agency that oversees that nation’s cancer effort — is a hard-earned example of the caliber of care we provide.
Here are a few highlights of successes from this year that demonstrate Roswell Park’s international leadership in cancer care and innovation that position Roswell Park as a destination center for cancer patients.
Discover how Roswell Park Comprehensive Cancer Center is transforming GI cancer care with cutting-edge advancements in minimally invasive robotic surgery, innovative hepatic artery pump therapy, and multidisciplinary treatment for recurrent rectal cancer. Achieving one of the nation’s lowest anastomotic leak rates to pioneering localized chemotherapy that minimizes toxicity, our expert team leverages state-of-the-art technology, AI-driven precision, and decades of high-volume experience.
December of 2024 brought the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility. The largest academic facility of its kind, will help to support the research and development of life-saving cell and gene therapies at Roswell Park, significantly grow its well-established research capabilities, and establish Roswell as one of the premier cell therapy discovery and development institutions in the nation.
SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center, now applies as a treatment for not just adult glioblastoma but a broader category of cancerous brain tumors: any malignant glioma in children or adults.
It’s important to us that patients understand the importance of receiving care at a center that can help them achieve the best possible outcomes, and many turn to national rankings for this guidance. That is why your vote for Roswell Park Comprehensive Cancer Center in the U.S. News & World Report’s Best Hospitals for Cancer expert opinion survey matters. Voting is now open! Cast your vote before closing date March 23, 2025.
Board-certified physicians in one of several cancer subspecialties who are registered as Doximity users are eligible to vote in the cancer category. You can register on Doximity at any time to vote during the voting period.
Being listed in U.S. News & World Report Best Hospitals is an honor and highlights the expertise of our faculty and staff who provide advanced care for the patients and families who need it most. Only a small percentage of physicians cast a vote, so your vote matters!
If eligible and registered on Doximity, you will receive an email from Doximity about the survey, or log on to Doximity during the survey period of late Feb to March. Once logged in, you will see a prompt on the homepage to click to take the survey.
BROADCASTMED